LeMaitre Vascular Q2 sales up 15% to $64.2M; raises FY guidance

LEMAITRE VASCULAR INC

2025-Q2 EPS reported $1.08 revenue$124,103,000

Q2 EPS $0.60 (+16% YoY); sales $64.2M (+15% organic) driven by catheters (+27%) and grafts (+19%).
Gross margin 70.0% (+110 bps); operating income $16.1M (+12%).
Full-year guidance raised: sales $248-$254M (midpoint +14%), EPS $2.23-$2.37 (midpoint +19%).
Quarterly dividend of $0.20/share declared, payable Sept 4, 2025 to holders of record Aug 21.
Cash increased $16.9M sequentially to $319.5M; $75M share repurchase program active through Feb 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.